Kamath Biosciences LLC

Heart-healthy human performance enhancement

“ANY OFFER TO SELL SECURITIES IN KAMATH BIOSCIENCES (KB), OR ANY SOLICITATION OF AN OFFER TO BUY SECURITIES IN KB, WILL ONLY BE MADE PURSUANT TO, AND SUBJECT TO, THE TERMS OF THE CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM OF KB.  ALL INFORMATION IN THIS PRESENTATION IS QUALIFIED BY THE MORE DETAILED INFORMATION IN THE MEMORANDUM AND ITS EXHIBITS.  ALL PROSPECTIVE INVESTORS SHOULD CAREFULLY REVIEW THE MEMORANDUM AND ITS EXHIBITS, INCLUDING THE RISK FACTORS DISCUSSION IN THE MEMORANDUM.” 

THIS PRESENTATION AND ITS DISCUSSION DO NOT CONSTITUTE AN OFFERING OF SECURITIES IN ANY STATE.

Uniting Performance and Health!

Kamath Biosciences

• Sports nutraceuticals company with 30+ years of biotechnology experience.

• Researched a very crowded market to understand what was wrong / missing as it related to overall cardiac / physical health.

• Developed, produced and launched a product to be a novel alternative with independently validated claims.

• Scientifically based, study validated body performance enhancing supplements specifically designed to improve physical performance, improve cardiac health, and not add contraindicated substances in the process.

Situation• Current products provide unbalanced or even unsafe levels

of ingredients and fillers:• Too much sodium:

• Actually dehydrates.• Raises blood pressure.

• Too much sugar:• Wastes body energy processing.• Improper carbohydrates.• Increases susceptibility of diabetes.

• Harmful stimulants:• Overworks your heart.

• Unwanted chemicals:• Chromium.• Nitric Oxide.• Vanadium.

Opportunity• Growing market:

• Powdered sports drinks $1.5B+.• Expanding at 8-10% annually.• 40+ audience accounts for over half

the consumers.

• 40+ demographic looking for performance products that also promote improved health:• Don’t know how to sort through the marketing hype.• At age 40, performance starts to show marked decline.• Retiring boomers are most fitness aware generation in history.• Fitness is a means to longer active life.• Less price sensitive. Generally a more affluent purchaser.

Target Market Need

• Supplement that:• Increases endurance and performance during activity by

improving natural cardiac performance.• Improves recovery after activity.• Provides needed vitamins and minerals.• Does not add inappropriate components.• Tastes good.

Our Solution• Patented blend of scientifically selected ingredients:

• Cardiac Nutrients (4)• Proteins (2)• Vitamins (6)• Electrolytes (4)

• Less than one gram of sugar.• 10 calories per serving.• No caffeine or other stimulants.• Great tasting!

Target Audience

• 40+ males and females.• Moderate to high activity levels.• Phase I - cyclists and runners.

Target Audience

• 40+ males and females.• Moderate to high active levels.• Phase II – additional target sports.

Defensibility of Intellectual Property and Validation of Cardiostrong• US Provisional Patent 61/849,907- Novel Composition

and Method to Physiologically Reduce Exercise Stress and Increase Exercise Endurance.

• Trademark Published in Principal Index - Serial Number 85840979.

• Cardiostrong is undergoing rigorous blinded

testing to gather the most comprehensive

panel of physiological parameters

as they affect human performance.

Strategic Opportunity

• Target a specific user that is as interested in overall cardiac health as they are in increased performance.

• Provide a product that outperforms competitive products while providing improved health benefits.

• Establish a market position as scientifically validated market leader in the next generation of performance / wellness enhancing supplements for active 40+ adults.

Goals & Objectives2014 2015 2016 2017 2018

Revenue $231,556 $1,125,698 $3,932,289 $10,407,202 $23,312,549COGS $132,188 $591,560 $2,013,866 $5,198,971 $11,342,377Gross Margin $99,368 $534,138 $1,918,423 $5,208,231 $11,970,172Expenses $127,680 $476,158 $600,617 $949,489 $1,146,789Net Operating Profit ($28,312) $57,981 $1,317,806 $4,258,741 $10,823,383

($5,000,000)

$0

$5,000,000

$10,000,000

$15,000,000

$20,000,000

$25,000,000

2014 2015 2016 2017 2018

Revenue

COGS

Gross Margin

Expenses

Net Operating Profit

Marketing Strategies• Pricing:

• Retail 10%+ above competitive offerings.• Gross margins growing to 50%.• No distribution / distributor pricing.

• Distribution:• Direct web.• Direct sales personnel.• High-value retailers / etailers (target market experts).

• Advertising & Promotion:• Social media / community building.• Blogs / expert education.• Key event exhibits.

Operational Plan• Production:

• Contract manufacturer.• Local inventory management.• Internal fulfillment.

• Finance:• Internal staffing.• Outside accounting firm.

• CRM / Support:• Internal staffing.

Team—Management and All Stars• Mr. Anant Kamath, Sc.M, JD, Founder and Product Development.• Mr. Jay Kamath, JD, Co-Founder and Chief Legal Counsel.• Ms. Sara Ternes – Director of Sales and Marketing.• Dr. Hiren Modi - Scientific Consultant.• Mr. Micheal Nelson – Marketing.• Mr. Scott Stevenson - Graphics Artist and Web Design.• Mr. Curtis Nelson and EDC. Business Practices, Management, Fund Raising.• Dr. David Luerkens, Luerken’s Laboratories. Expertise in particle

and physical chemistry, food flavorings, solubility. Key Prior Project—Truvia.• Mr. Tom Ries. Product Testing/Development, 2013 Chicago Marathon Men’s

Top 50 Finisher. Time of 2 hrs 26 minutes.• Ms. Gaby Bunten (Pictured on Right). Product Testing/Development, Qualifier,

World International Triathlon Union Championships, London, England.• Mr. Brenden Hardy. Product Testing/Development, President of

The University of Iowa Cycling Club/Team.• Mr. Adam Kassem. Product Testing/Development, Triathlete and Personal

Trainer.• Ms. Jordan Ritchie. Sales/Marketing.